Conduction system pacing in congenital heart disease
Óscar Cano, MD, PhD,1,2 Gopi Dandamudi,
MD,3 Robert D. Schaller, DO,4 Víctor
Pérez-Roselló, MD,1 Hebert D. Ayala,
MD,1 Maite Izquierdo, MD, PhD,1Joaquín Osca, MD, PhD,1 María-José Sancho-Tello, MD,
MD,1 Joaquín Rueda, MD, PhD,1,2Eladio Ruiz, MD,1 Beatriz Insa, MD,1Luis Martínez-Dolz, MD, PhD,1,2 Pugazhendhi
Vijayaraman, MD5
1 Electrophysiology Section, Adult Congenital Heart
Disease Section and Paediatric Cardiology Section, Cardiology
Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
2 Centro de Investigaciones Biomédicas en RED en
Enfermedades Cardiovasculares (CIBERCV), Spain
3 Cardiovascular Service Line, Cardiology,
CHI-Franciscan Health System, Tacoma, Washington, USA.
4 Electrophysiology Section, Division of
Cardiovascular Medicine, University of Pennsylvania, Philadelphia,
Pennsylvania, USA.
5 Geisinger Heart Institute, Wilkes-Barre,
Pennsylvania, USA.
Word count : 4986
Conflict of interest : Dr. Cano has received consultant fees
from Medtronic and Boston Scientific. Dr. Schaller has received
honoraria and/or research funding from Abbott, Biotronik, Boston
Scientific, Medtronic, and Philips. Dr. Dandamudi has served as a
speaker and consultant for Medtronic; and served onthe Advisory Board
for Biotronik. Dr. Vijayaraman has received honoraria, been a
consultant, conducted research, and received fellowship support from
Medtronic; has been a consultant for Boston Scientific, Abbott, and
Biotronik; and has a patent pending for the His bundle pacing delivery
tool. All other authors have nothing to disclose.